NYSE:EVH - Evolent Health Stock Price, Forecast & News

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Evolent Health Inc (NYSE:EVH) issued its quarterly earnings results on Tuesday, November, 5th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.12) by $0.03. The technology company earned $220.14 million during the quarter, compared to analyst estimates of $217.90 million. Evolent Health had a negative return on equity of 6.93% and a negative net margin of 15.02%. The company's revenue was up 46.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.04) earnings per share. View Evolent Health's Earnings History.

Evolent Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Evolent Health.

7 equities research analysts have issued 12-month price targets for Evolent Health's shares. Their forecasts range from $10.00 to $18.00. On average, they anticipate Evolent Health's stock price to reach $14.31 in the next twelve months. This suggests a possible upside of 27.9% from the stock's current price. View Analyst Price Targets for Evolent Health.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health.

News articles about EVH stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Evolent Health earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave news stories about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Evolent Health.

Some companies that are related to Evolent Health include Mantech International (MANT), R1 RCM (RCM), Franklin Covey (FC), Jupai (JP), PHI Group (PHIL) and Rainmaker Systems (VCTL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Energy Transfer LP Unit (ET), Advanced Micro Devices (AMD), Transocean (RIG) and NVIDIA (NVDA).

(EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Evolent Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (3.42%) and Peregrine Capital Management LLC (1.41%). Company insiders that own Evolent Health stock include Cheryl Scott, Doug S Aron, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Michael D'amato, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Institutional Ownership Trends for Evolent Health.

EVH stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC and Peregrine Capital Management LLC. View Insider Buying and Selling for Evolent Health.

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of EVH stock can currently be purchased for approximately $11.19.

Evolent Health has a market capitalization of $946.79 million and generates $627.06 million in revenue each year. The technology company earns $-52,660,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis. Evolent Health employs 3,800 workers across the globe.View Additional Information About Evolent Health.

The official website for Evolent Health is http://www.evolenthealth.com/.

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.